Overexpression of NCAM and its polysialylated form (PSA-NCAM) have been reported in various metastatic cancers, including neuroblastoma[9], small cell lung carcinoma[10], renal cell carcinomas[11], and Wilms’ tumor[12]. This evidence concerns the gene NCAM1 and renal cell carcinoma.